Hardman Johnston Global Advisors LLC Reduces Position in UnitedHealth Group Incorporated (NYSE:UNH)

Hardman Johnston Global Advisors LLC lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.8% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 63,582 shares of the healthcare conglomerate’s stock after selling 4,624 shares during the quarter. UnitedHealth Group accounts for 1.5% of Hardman Johnston Global Advisors LLC’s portfolio, making the stock its 23rd largest position. Hardman Johnston Global Advisors LLC’s holdings in UnitedHealth Group were worth $37,175,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. China Universal Asset Management Co. Ltd. boosted its holdings in UnitedHealth Group by 20.6% in the first quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock valued at $5,376,000 after purchasing an additional 1,857 shares during the last quarter. Quent Capital LLC grew its holdings in UnitedHealth Group by 5.5% during the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock worth $2,076,000 after acquiring an additional 217 shares during the period. Embree Financial Group lifted its holdings in UnitedHealth Group by 12.1% in the first quarter. Embree Financial Group now owns 613 shares of the healthcare conglomerate’s stock valued at $303,000 after acquiring an additional 66 shares during the period. Valley Wealth Managers Inc. grew its stake in shares of UnitedHealth Group by 8.7% during the 1st quarter. Valley Wealth Managers Inc. now owns 1,149 shares of the healthcare conglomerate’s stock worth $568,000 after purchasing an additional 92 shares during the period. Finally, SPC Financial Inc. lifted its stake in shares of UnitedHealth Group by 3.6% in the 1st quarter. SPC Financial Inc. now owns 5,185 shares of the healthcare conglomerate’s stock valued at $2,565,000 after purchasing an additional 179 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the subject of a number of analyst reports. UBS Group decreased their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Truist Financial restated a “buy” rating and issued a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Bank of America reduced their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Finally, TD Cowen increased their target price on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Stock Performance

NYSE UNH opened at $566.96 on Wednesday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $608.63. The company has a current ratio of 0.91, a quick ratio of 0.88 and a debt-to-equity ratio of 0.74. The stock has a fifty day simple moving average of $580.96 and a 200-day simple moving average of $543.36. The stock has a market cap of $523.54 billion, a PE ratio of 36.94, a P/E/G ratio of 1.64 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the firm posted $6.56 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.48%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.